Opinion & analysis

Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says

Explore the details behind the FDA digital health tools platform set for release in the fall of 2018, an initiative designed to allow health software applications and accompanying new drugs to be approved concurrently, further streamlining the approval process for certain combination products.

Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says

Biosimilar Suffixes Appear Superfluous In Adverse Event Reporting

Part B Payment Model Indexing Commercial Discounts Proposed By Genentech

Adaptive Clinical Trial Designs: US FDA Provides Checklist To Begin Study

OTC Distribution in Europe – The New Global Agenda

Mail Order and Internet Pharmacy in Europe

Telehealth Reforms Praised At Senate Hearing

Technology Gap Separates OTC Drug Firms From SelfCare Sales Growth

Reckitt Reaps ROI Reward In Geo-Targeted Symptoms App Promoting Mucinex, Delsym

Philips To Create More Context, Connectedness And Continuity And Shift Sick Care To Health Care

Game On For Akili’s Cognitive Control Tech

Engaging Patients and Navigating Laws: What To Consider When Developing Health Apps

Biogen CMO Notes iPhone’s Potential For Early Detection of Alzheimer’s

Behind The Scenes Of Digital Health: Medtech Players And Partners

Telehealth, Wearables and Apps – Report 3